02/12/2026

Aurore Delvenne, a researcher at Maastricht University, will be presenting the findings of her analy...

02/09/2026

The PRISM2 dataset and biosample collection are now requestable through the EPND Hub. To learn more ...

01/13/2026

The Innovative Health Initiative has just launched ACCESS-AD, to advance timely diagnosis and equita...

11/10/2025

Last month, EPND convened its 4th Annual Meeting in Brussels, Belgium: celebrating recent achievemen...

10/02/2025

EPND recently hosted a webinar showing how our platform for data and biosample sharing can accelerat...

08/01/2025

EPND partners presented updates on their work at the 2025 Alzheimer Association International Confer...

06/25/2025

EPND recently hosted a webinar introducing the EPND Hub - a secure environment designed to accelerat...

06/25/2025

EPND is hosting a 2nd webinar in its public series, taking place on Thursday 10 July. This one-hour ...

05/22/2025

The European Platform for Neurodegenerative Diseases (EPND) has released its first harmonised biomar...

05/19/2025

EPND has launched a new ELSI Support Desk to support researchers in navigating the ethical, legal, a...

04/11/2025

Join us for the first webinar in EPND’s 2025 public series and discover how the EPND Hub's technical...

04/03/2025

Our CBG-MEB partner Audrey Hermans, presented her PhD research at AD/PD 2025, in Vienna. In this int...

04/02/2025

Our Sanofi partner, Ram Krishnan, presented some of EPND's latest biomarker research findings at AD/...

12/12/2024

The gMAD/COSCODE study, led by Prof. Giovanni Frisoni (University of Geneva) is investigating the mo...

12/11/2024

Today, we are excited to launch the EPND Hub, a major expansion of our data and biosample catalogue ...

11/21/2024

A few weeks ago, EPND convened its 3rd Annual Meeting in Madrid, Spain: celebrating recent achieveme...

10/10/2024

The 34th annual Alzheimer Europe conference showcased several initiatives that are shaping the futur...

09/05/2024

Our latest biomarker research results were presented at AAIC in August, by our Maastricht University...

07/23/2024

EPND has launched an open Call for Expressions of Interest to leverage neurodegeneration biosamples ...

04/26/2024

Our partner Marina Boccardi of DZNE presents the EPND Glossary, a tool designed to enhance transdisc...

04/18/2024

The OPDC Discovery study looks at how movement and cognition changes with normal ageing and during t...

03/07/2024

Our co-Lead, Phil Scordis, shared the mission, goals and outcomes of EPND at the AD/PD conference, d...

03/04/2024

Our project co-Lead, Phil Scordis, will present EPND at a sponsored symposium on data and sample sha...

01/30/2024

EPND congratulates consortium partners on the launch of AD-RIDDLE...

01/11/2024

In a new Nature Aging paper, EPND researchers characterise five molecular subtypes of Alzheimer's di...

11/17/2023

At the first event of its kind, EPND engaged with people affected by Alzheimer's disease and related...

10/18/2023

EPND was featured at a Special Symposium on new discoveries from shared data, at the 33rd Annual Alz...

10/08/2023

Meet the EPND experts in biomarker discovery, development, validation, who will share learnings and ...

09/21/2023

In a special feature for World Alzheimer's Day, we discuss a recent implementation study that has id...

08/09/2023

EPND was well-represented at this year's AAIC conference, with posters and a presence in the exhibit...

07/06/2023

Professor Teunissen is an expert on biomarkers for Alzheimer's disease and multiple sclerosis, leadi...

05/24/2023

This cohort profile features the BF-PilotAD cohort, part of the Swedish BioFINDER study. ...

04/30/2023

In a final feature for Parkinson's Awareness Month, we present the results of a groundbreaking new b...

04/25/2023

An interview with Professor Michele Hu, a leading Parkinson's disease researcher and co-principal in...

04/17/2023

En este artículo especial con motivo del Mes de Concienciación sobre el Parkinson, hablamos con el p...

04/17/2023

In a special article for Parkinson's awareness month, we speak to the president of the Spanish Parki...

12/22/2022

26 - 27 January 2023: conference on "Precision medicine in Parkinson's Disease: past lessons and con...

12/15/2022

Project consortium members gather in Amsterdam for the first EPND Annual Meeting...

11/21/2022

Patient privacy and the GDPR: an EPND interview with Adrian Thorogood...

09/21/2022

Nothing about us, without all of us: an EPND interview with Chris Roberts and Jayne Goodrick...

08/09/2022

International Workgroup issues recommendations for the clinical use of blood-based biomarkers in Alz...

08/05/2022

An EPND interview with Marianna Rizzo and Audrey Hermans...

07/08/2022

AAIC workshop on fluid biomarkers features EPND partners, Charlotte Teunissen and Henrik Zetterberg...

06/20/2022

BBMRI-ERIC is recruiting a Legal Expert to join its ELSI team and contribute to EPND and other proje...

02/07/2022

Annual AD/PD conference to feature several EPND partners ...

02/04/2022

Large-scale biomarker study provides new prevalence estimates for Alzheimer’s disease brain patholog...

11/29/2021

This year’s conference will be held under the motto “Resilience in dementia: Moving beyond the COVID...

11/02/2021

New European initiative will build a collaborative platform for data and sample sharing, to accelera...